BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GATC Biotech Setting a Global Example: Three Accredited Next Generation Sequencing Platforms Under One Roof


4/23/2013 11:50:09 AM

Konstanz, Germany, April 23, 2013 / B3C newswire / – With official accreditation of yet another sequencing platform, GATC Biotech presents the worldwide first trio of accredited NGS platforms under one roof. After successful accreditation the technology platforms Ilumina HiSeq and Roche GS FLX, the high quality of PacBio RS sequencing has now officially been confirmed by the national accreditation body for the Federal Republic of Germany (DAkkS).

The combination of three accredited Next Generation Sequencing platforms under one roof is said to be unique globally. The Pacific Biosciences PacBio RS platform located at GATC Biotech’s headquarter has been officially accredited according to EN ISO/IEC 17025. The accreditation of PacBio RS adds an extensive variety of efficiency and quality to the pre-high-quality fleet of different platforms. Thereby, the company achieves maximum exhaustion of all Next Gen Systems available within its own laboratory.

Being Europe’s first sequencing provider to use the PacBio RS platform, GATC Biotech emphasises its position on the international sequencing market. The third accreditation within one year demonstrates the latest state-of-the-art standards in the company’s methods, technologies and data quality that are pursued by responsible staff members at all times. As Dr. Marcus Benz, COO of GATC Biotech AG, explains:”The flexible accreditation of various platforms allows our customers to benefit from the firsthand and experienced support and to rely on an all-time audited international quality standard.”

About GATC Biotech

GATC Biotech is Europe’s leading service provider of DNA sequencing with more than 10.000 academic and industrial customers worldwide. For over two decades, we have offered sequencing and bioinformatics solutions from single samples up to large scale projects. GATC Biotech has sequenced more than 5 million samples, ten thousands of bacterial, plant and other whole genomes as well as hundreds of whole human genomes.

Having Agilent and Illumina Certified Service Provider status, GATC Biotech offers true multiplatform sequencing using all leading sequencing technologies in its own labs. In order to evaluate these immense data quantities professionally, GATC Biotech keeps its own IT farm.

Headquartered in Constance, Germany, the company houses its ISO 17025 certified Genome and Diagnostic Centre with a focus on Next and Third Generation sequencing. The European Custom Sequencing Centre located in Cologne focuses on Sanger Sequencing and serving as the logistical hub within Europe. All laboratories have highly integrated and fully automatic processing pipelines and enable full compliance with latest state-of-the-art quality standards. Since 2010, GATC Biotech has been a key supplier for the International Cancer Genome Project.

GATC Biotech´s subsidiary LifeCodexx emphasises the development of clinically validated molecular diagnostic tests and offers a risk-free alternative to common invasive examination methods such as amniocentesis.

Press Contact:

GATC Biotech AG

Lisa-Annina Quintes

Jakob-Stadler-Platz 7

78462 Konstanz

Germany

Phone: +49 (0) 7531-81604117

Fax: +49 (0) 7531-816081

Email: l.quintes@gatc-biotech.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES